Impairment of In Vitro and In Vivo Heart Function in Angiotensin-(1-7) Receptor Mas Knockout Mice
- 1 May 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 47 (5) , 996-1002
- https://doi.org/10.1161/01.hyp.0000215289.51180.5c
Abstract
In this study we investigated the effects of the genetic deletion of the angiotensin (Ang)-(1-7) receptor Mas on heart function. Localization of Mas in the mouse heart was evaluated by binding of rhodamine-labeled Ang-(1-7). Cardiac function was examined using isolated heart preparations. Echocardiography was used to confirm the results obtained with isolated heart studies. To elucidate the possible mechanisms involved in the cardiac phenotype observed in Mas −/− mice, whole-cell calcium currents in cardiomyocytes and the expression of collagen types I, III, and VI and fibronectin were analyzed. Ang-(1-7) binding showed that Mas is localized in cardiomyocytes of the mouse heart. Isolated heart techniques revealed that Mas-deficient mice present a lower systolic tension (average: 1.4±0.09 versus 2.1±0.03 g in Mas +/+ mice), ±dT/dt, and heart rate. A significantly higher coronary vessel resistance was also observed in Mas-deficient mice. Echocardiography revealed that hearts of Mas-deficient mice showed a significantly decreased fractional shortening, posterior wall thickness in systole and left ventricle end-diastolic dimension, and a higher left ventricle end-systolic dimension. A markedly lower global ventricular function, as defined by a higher myocardial performance index, was observed. A higher delayed time to the peak of calcium current was also observed. The changes in cardiac function could be partially explained by a marked change in collagen expression to a profibrotic profile in Mas-deficient mice. These results indicate that Ang-(1-7)-Mas axis plays a key role in the maintenance of the structure and function of the heart.Keywords
This publication has 35 references indexed in Scilit:
- Angiotensin-(1–7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effectsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Mineralocorticoid Receptor Blocker Increases Angiotensin-Converting Enzyme 2 Activity in Congestive Heart Failure PatientsCirculation Research, 2005
- Evidence for a Functional Interaction of the Angiotensin-(1–7) Receptor Mas With AT 1 and AT 2 Receptors in the Mouse HeartHypertension, 2005
- Angiotensin-(1–7) inhibits growth of cardiac myocytes through activation of themasreceptorAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Nonpeptide AVE 0991 Is an Angiotensin-(1–7) Receptor Mas Agonist in the Mouse KidneyHypertension, 2004
- Upregulation of Angiotensin-Converting Enzyme 2 After Myocardial Infarction by Blockade of Angiotensin II ReceptorsHypertension, 2004
- Angiotensin 1–7 increases quantal content and facilitation at the frog neuromuscular junctionBrain Research, 2002
- Non-invasive echocardiographic studies in miceLife Sciences, 2001
- Expression of the mouse and rat mas proto‐oncogene in the brain and peripheral tissuesFEBS Letters, 1995
- Effects of angiotensin II and angiotensin-(1-7) on the release of [3H]norepinephrine from rat atria.Hypertension, 1994